SR ONE CAPITAL MANAGEMENT, LP Q2 2023 Filing
Filed August 10, 2023
Portfolio Value
$231.9B
Holdings
6
Report Date
Q2 2023
Filing Type
13F-HR
All Holdings (6 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ACLXARCELLX INC | 3,946,630 | $124.8B | 53.81% | |
| 2 | DSGNDESIGN THERAPEUTICS INC | 6,526,476 | $41.1B | 17.73% | |
| 3 | MLYSMINERALYS THERAPEUTICS INC | 1,794,600 | $30.6B | 13.19% | |
| 4 | SPRYARS PHARMACEUTICALS INC | 4,012,903 | $26.9B | 11.59% | |
| 5 | EFTREFFECTOR THERAPEUTICS INC | 6,822,114 | $5.6B | 2.41% | |
| 6 | NKTXNKARTA INC | 1,333,333 | $2.9B | 1.26% |